22
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Immune memory is tailored by cues that lymphocytes perceive during priming. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a situation in which nascent memory could be tracked through additional antigen exposures. Both SARS-CoV-2 infection and vaccination induce multifaceted, functional immune memory, but together they engender improved protection from disease, termed hybrid immunity. We therefore investigated how vaccine-induced memory is shaped by previous infection. We found that following vaccination, previously infected individuals generated more SARS-CoV-2 RBD-specific memory B cells and variant-neutralizing antibodies and a distinct population of IFN-γ and IL-10-expressing memory SARS-CoV-2 spike-specific CD4 + T cells than previously naive individuals. While additional vaccination could increase humoral memory in previously naive individuals, it did not recapitulate the distinct CD4 + T cell cytokine profile observed in previously infected subjects. Thus, imprinted features of SARS-CoV-2-specific memory lymphocytes define hybrid immunity.

          Abstract

          The strong immunity against SARS-CoV-2 in vaccinated individuals that have previously been infected can be explained by a combination of RBD-specific memory B cells, variant-neutralizing antibodies and a specific population of CD4 + T cells.

          Related collections

          Author and article information

          Journal
          Cell
          Cell
          Cell
          Published by Elsevier Inc.
          0092-8674
          1097-4172
          17 March 2022
          17 March 2022
          Affiliations
          [1 ]Department of Immunology, University of Washington School of Medicine, Seattle, WA, 98109, USA
          [2 ]Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA, 98101, USA
          [3 ]Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, 98109, USA
          [4 ]Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, 98109, USA
          [5 ]Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle, WA, 98101, USA
          Author notes
          []Corresponding author
          [6]

          These authors contributed equally

          [7]

          Lead contact

          Article
          S0092-8674(22)00328-2
          10.1016/j.cell.2022.03.018
          8926873
          35413241
          61c7990b-32fc-48e9-8f07-666eadfe49e8
          © 2022 Published by Elsevier Inc.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 13 January 2022
          : 23 February 2022
          : 14 March 2022
          Categories
          Article

          Cell biology
          sars-cov2,covid-19,memory b cell,memory t cell,hybrid immunity,human,vaccine,adaptive immune response

          Comments

          Comment on this article